For Research Use Only. Not for use in diagnostic procedures.
Rapid and Cost-Effective Identification of SARS-CoV-2 Variants
The mutated SARS-CoV-2 has created a new challenge for labs and communities around the world. These concerned mutations increase COVID-19 transmissibility and possibly reduces the COVID-19 vaccine effectiveness. While next-generation sequencing-based assays are routinely used to track the new SARS-CoV-2 variants, they require sophisticated NGS lab equipment not accessible by most clinical laboratories, and the assays are expensive with a long turnaround time.
To provide a viable alternative, BGI has developed a rapid, sensitive and cost-effective solution with the assays run on PCR machines commonly found in most molecular diagnostic labs. These assays can easily be integrated into our current Emergency Use Authorization (EUA) workflow that includes high-throughput viral RNA extraction and SARS-CoV-2 detection for testing hundreds or thousands of samples a day.
BGI is offering a suite of SARS-CoV-2 mutation detection kits that labs can purchase together with our EUA RT-PCR SARS-CoV-2 detection kit as a bundle to identify the SARS-CoV-2 and differentiate the lineage mutations. These mutation detection kits can be used independently without using the EUA detection kit.
* Frequently Asked Questions (FAQ)
* Request a quote and your BGI representative will reply to you within 24 hours.